HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY

Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/ telehealth flexibility; Rural healthcare; Marketplace Renewal Notices; Surprise Billing; Prior Authorization; Managed Care Organizations; Maternal Health; Hospital billing; Individual Market Reforms and eAPTC Extension; Healthcare Affordability. H.R.1909 - Preventing Maternal Deaths Reauthorization Act of 2025 To amend the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives, and for other purposes. Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (Introduced 03/06/2025) H.R.1627 - TREATS Act To amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes. Sponsor: Rep. Norcross, Donald [D-NJ-1]

Medicare Advantage; Medicare/Transparency; Medicaid Cuts; Medicare Advantage & MA Rate Notice; Youth Mental Health; community engagement implementation; Site neutral payment reform. H.R.4077 - GUARD Veterans Health Care Act To amend title 38, United States Code, and the Social Security Act to permit recovery from the Department of Veterans Affairs of costs from Medicare Advantage and Medicare prescription drug plans and to modify the authority for recovery by the United States of reasonable charges for certain care or services furnished to veterans for non-service-connected disabilities, and for other purposes. Sponsor: Rep. Doggett, Lloyd [D-TX-37] S.1105 - No UPCODE Act To amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage. Sponsor: Sen. Cassidy, Bill [R-LA]

Generics access; Prescription Drug Cost; Step Therapy H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2]